Skip to content

Integrative single-cell transcriptomic and metabolic profiling reveals lactate-driven glycolytic reprogramming and histone lactylation in colorectal cancer liver metastasis.

Oct 2026 · Journal of Pathology · 0 citations · 54 references
Medicine

TL;DR

A metabolic-epigenetic-immune axis in which tumor glycolysis reprograms immunity via lactate-induced CDH1 shedding is identified, which redefines CDH1 as a dual-function molecule and reveals actionable targets for metastatic CRC.

Abstract

Metabolic reprogramming and immune evasion are hallmarks of cancer metastasis, but how tumor metabolism shapes the immune microenvironment during colorectal cancer (CRC) liver metastasis remains poorly understood. The role of E-cadherin (CDH1) beyond cell adhesion is unexplored. We integrated single-cell RNA sequencing, pseudotime trajectory inference, and in vivo/in vitro functional assays in primary and liver-metastatic CRC models. CellChat was used to map intercellular communication. Histone lactylation, ADAM10 activation, and CDH1 shedding were validated by biochemical and immunohistochemical assays. PGK1-driven glycolysis is upregulated in liver metastases and promotes metastatic progression. Elevated lactate induces histone H3K18 lactylation, activating ADAM10 expression. ADAM10 cleaves CDH1, releasing its soluble ectodomain. This fragment acts as a ligand for KLRG1 on T cells, driving exhaustion and immunosuppression. Cell-cell communication analysis confirmed CDH1-KLRG1 as a top differentially activated pathway in metastasis. Functionally, targeting PGK1 or blocking CDH1 shedding inhibits liver metastasis and restores T-cell function. We identify a metabolic-epigenetic-immune axis in which tumor glycolysis reprograms immunity via lactate-induced CDH1 shedding. Soluble CDH1 functions as an immunomodulatory signal, linking metabolic activity to T-cell exhaustion. This redefines CDH1 as a dual-function molecule and reveals actionable targets for metastatic CRC. © 2026 The Pathological Society of Great Britain and Ireland.

View source

Similar papers

Open access Sep 2026

A CCL4-enriched NK-cell transcriptional state is associated with inflammatory and myeloid-stromal programs in colorectal cancer liver metastasis

CRLM is associated with altered NK-cell representation among recovered cells and a reproducible CCL4-enriched inflammatory NK-cell transcriptional state and its association with inflammatory and myeloid-stromal programs across independent, spatial and model-system analyses provides a focused framework for future lineag...

Li-Hong Lin, Michael Xu, Xiao-Chun Gu et al. · 0 citations
Open access Sep 2026

Integrative single-cell and bulk transcriptomics uncovers a lipid metabolism-related lncRNA signature alongside the ELFN1-AS1/LYPLA1 axis driving osteosarcoma progression

The oncogenic ELFN1-AS1/LYPLA1 regulatory cascade is characterized as a potential biomarker and therapeutic target for precision management of osteosarcoma and establishes an LMRL-based for osteosarcoma prognostic stratification that reflects immune, genomic and therapeutic heterogeneity.

Xian-Fu Wei, Zhi-Peng Wang, Qiang Yang et al. · 0 citations
Sep 2026

Integrated single-cell and spatial transcriptomic analyses reveal malignant epithelial glycolytic heterogeneity and spatial niche remodeling during colorectal cancer progression

Findings indicate that glycolytic heterogeneity is a key feature of CRC malignant epithelial cells and is closely associated with tumor progression, microenvironmental remodeling, and clinical outcomes.

Jin-Yu Xiao, Shan-Shan Heng, Jia-Yu Li et al. · 0 citations
Open access Oct 2026

FOXC1–GMDS axis-driven glycolytic reprogramming promotes tumor progression in triple-negative breast cancer

Triple-negative breast cancer (TNBC) is a clinically aggressive subtype that is highly reliant on glycolytic metabolism. Despite this well-characterized metabolic feature, the molecular mechanisms governing glycolytic fitness and the therapeutic potential to exploit these metabolic adaptations remain poorly defined....

Ming-Kai Gong, Mei-Juan Gong, Xiang-Han Zhao et al. · 0 citations
Open access Oct 2026

SND1 promotes colorectal cancer progression and metastasis by stabilizing HK2 through the inhibition of FBW7-mediated ubiquitination.

BACKGROUND Metabolic reprogramming, particularly enhanced aerobic glycolysis, is a hallmark of colorectal cancer (CRC) progression and metastasis. However, the key regulatory mechanisms linking glycolytic remodeling to metastatic progression remain incompletely understood. METHODS We integrated single-cell RNA sequen...

Hao-Ran Zhang, Jin-Lin Nie, Na Li et al. · 0 citations
Open access Oct 2026

Integrated spatial and single-cell transcriptomics uncover IFI6⁺ regulatory T-cells and SPP1⁺ macrophages immunosuppressive niches in colorectal cancer.

This study uncovered previously unrecognized immunosuppressive cell populations and key immune regulators that advance understanding of CRC immune evasion and highlight potential targets for personalized immunotherapy.

Dominika Miroszewska, Shi-Yang Song, Víctor Urbiola-Salvador et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.